Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

HOXA-AS3 Promotes Proliferation and Migration of Hepatocellular Carcinoma Cells via the miR-455-5p/PD-L1 Axis
Cheng Zeng, Shaojun Ye, Yu Chen, et al.
Journal of Immunology Research (2021) Vol. 2021, pp. 1-12
Open Access | Times Cited: 21

Showing 21 citing articles:

MicroRNAs as regulators of immune checkpoints in cancer immunotherapy: targeting PD-1/PD-L1 and CTLA-4 pathways
Arefeh Zabeti Touchaei, Sogand Vahidi
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 34
A comprehensive review on the emerging role of long non-coding RNAs in the regulation of NF-κB signaling in inflammatory lung diseases
Asif Ahmad Bhat, Obaid Afzal, Neetu Agrawal, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 126951-126951
Closed Access | Times Cited: 37
Melatonin suppresses PD-L1 expression and exerts antitumor activity in hepatocellular carcinoma
Rui Guo, Visweswara Rao Pasupuleti, Bo Liao, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Recent progress in the immunotherapy of hepatocellular carcinoma: Non-coding RNA-based immunotherapy may improve the outcome
Fatemeh Afra, Amir Ali Mahboobipour, Amir Salehi Farid, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115104-115104
Open Access | Times Cited: 20
The interplay between noncoding RNAs and drug resistance in hepatocellular carcinoma: the big impact of little things
Yuan Fang, Xiaoli Zhang, Hanfei Huang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 15
The current status and future of PD-L1 in liver cancer
Liyuan Hao, Shenghao Li, Jiali Deng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
Long non-coding rnas as key modulators of the immune microenvironment in hepatocellular carcinoma: implications for Immunotherapy
Siqi Zhao, Fei Chen, Lingyu Hu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Modulation of the skin and gut microbiome by psoriasis treatment: a comprehensive systematic review
A. A. Korneev, Maria Peshkova, Polina I. Koteneva, et al.
Archives of Dermatological Research (2024) Vol. 316, Iss. 7
Closed Access | Times Cited: 3
Clinical Significance of Non-Coding RNA Regulation of Programmed Cell Death in Hepatocellular Carcinoma
Wuyu Chen, Minghao Ruan, Minghao Zou, et al.
Cancers (2023) Vol. 15, Iss. 16, pp. 4187-4187
Open Access | Times Cited: 7
Role of Anti-Inflammatory Diet and Fecal Microbiota Transplant in Psoriatic Arthritis
Rajesh Gopalarathinam, Reethika Sankar, Sizheng Steven Zhao
Clinical Therapeutics (2024) Vol. 46, Iss. 7, pp. 588-596
Closed Access | Times Cited: 2
Prognostic value of lncRNA HOXA‐AS3 in cervical cancer by targeting miR‐29a‐3p and its regulatory effect on tumor progression
Hui Xu, Yan Tang, Chuanyong He, et al.
Journal of Obstetrics and Gynaecology Research (2022) Vol. 48, Iss. 10, pp. 2594-2602
Closed Access | Times Cited: 8
The integrated comprehension of lncRNA HOXA-AS3 implication on human diseases
Qinfan Yao, Cuili Wang, Yucheng Wang, et al.
Clinical & Translational Oncology (2022) Vol. 24, Iss. 12, pp. 2342-2350
Open Access | Times Cited: 8
miRNome profiling of lung cancer metastases revealed a key role for miRNA-PD-L1 axis in the modulation of chemotherapy response
Roberto Cuttano, Tommaso Colangelo, Juliana Guarize, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Role of HOXA1-4 in the development of genetic and malignant diseases
Lumin Wang, Haifeng Sun, Li Cao, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Tumour-regulatory role of long non-coding RNA HOXA-AS3
Zhi Xiong Chong, Wan Yong Ho, Swee Keong Yeap
Progress in Biophysics and Molecular Biology (2024) Vol. 189, pp. 13-25
Open Access | Times Cited: 1
Preclinical techniques for drug discovery in psoriasis
Pranjal P. Gujarathi, Rashmi H Korat, Piyush S Gujarathi
International Immunopharmacology (2024) Vol. 137, pp. 112378-112378
Closed Access | Times Cited: 1
The Interaction of Programmed Cell Death Protein and Its Ligands with Non-Coding RNAs in Neoplasms: Emerging Anticancer Immunotherapeutics
Mahmoud Kandeel, Duaa Althumairy, Ibrahim M. El-Sabagh, et al.
Processes (2023) Vol. 11, Iss. 2, pp. 538-538
Open Access | Times Cited: 1
Pinpointing Functionally Relevant miRNAs in Classical Hodgkin Lymphoma Pathogenesis
Yujia Pan, Roza Cengiz, Joost Kluiver, et al.
Cancers (2024) Vol. 16, Iss. 6, pp. 1126-1126
Open Access
LncRNA HOXA-AS3 promotes cell proliferation and invasion via targeting miR-218-5p/FOXP1 axis in osteosarcoma
Rong Li, Pingbo Chen, Yubo Zhou, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Interplay between programmed death-ligand 1 and non-coding RNAs
Soudeh Ghafouri‐Fard, Hamed Shoorei, Bashdar Mahmud Hussen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 2
A concise review of the regulatory, diagnostic, and prognostic implications of HOXB-AS3 in tumors
Hongze Wu, Jiarong Ye, Mengqi Zhang, et al.
Journal of Cancer (2023) Vol. 15, Iss. 3, pp. 714-728
Open Access
Page 1

Scroll to top